Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

BDRX — Biodexa Pharmaceuticals Plc Dilution Risk Tracker

Track BDRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDRX — Get alerts when the score changes →

As of October 13, 2026, Biodexa Pharmaceuticals Plc (BDRX) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Biodexa Pharmaceuticals Plc has a market capitalization of $86.53B, 225.82B shares outstanding, 8 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BDRX.
🔔 Track BDRX — Get forecast alerts →

Market Data

Market Cap$86.53B
Shares Outstanding225.82B
FloatN/A
Cash$11.48M
Debt$82.1K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore47/100DilutionWatch score record
Shares Outstanding225.82BVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$86.53BMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

8 institutional holders · 63.2K shares
#1 Sabby Management, LLC 38.1K shares
#2 Armistice Capital, LLC 20.0K shares
#3 Gamma Investing LLC 2.8K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

BDRX's DilutionScore is currently 47/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 67/100 (High risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202647/100MEDIUM6 days
Aug 22 – Oct 07, 202667/100HIGH47 days
Jul 16 – Aug 21, 202659/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BDRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BDRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BDRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for BDRX
BDRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.